Jurjan Aman

2.6k total citations · 1 hit paper
62 papers, 1.1k citations indexed

About

Jurjan Aman is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jurjan Aman has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 16 papers in Hematology and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jurjan Aman's work include Pulmonary Hypertension Research and Treatments (16 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Eosinophilic Disorders and Syndromes (9 papers). Jurjan Aman is often cited by papers focused on Pulmonary Hypertension Research and Treatments (16 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Eosinophilic Disorders and Syndromes (9 papers). Jurjan Aman collaborates with scholars based in Netherlands, United States and United Kingdom. Jurjan Aman's co-authors include Geerten P. van Nieuw Amerongen, A. B. Johan Groeneveld, Victor W.M. van Hinsbergh, Harm Jan Bogaard, Coert Margadant, Jan van Bezu, Xue D. Manz, Anton Vonk Noordegraaf, Etto C. Eringa and Stephan Huveneers and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

Jurjan Aman

56 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathology and pathobiology of pulmonary hypertension: current insights and future directions

2024 43 citations Christophe Guignabert, Jurjan Aman et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Jurjan Aman

Since Specialization

Citations

This map shows the geographic impact of Jurjan Aman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurjan Aman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurjan Aman more than expected).

Fields of papers citing papers by Jurjan Aman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jurjan Aman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurjan Aman. The network helps show where Jurjan Aman may publish in the future.

Co-authorship network of co-authors of Jurjan Aman

This figure shows the co-authorship network connecting the top 25 collaborators of Jurjan Aman. A scholar is included among the top collaborators of Jurjan Aman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jurjan Aman. Jurjan Aman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and radiologic characteristics of chronic thromboembolic pulmonary hypertension patients without a history of acute venous thromboembolism 2025 ·Journal of Thrombosis and Haemostasis ·(unknown), Josien van Es, (unknown), (unknown), (unknown), Jurjan Aman, Frederikus A. Klok, Harm Jan Bogaard, Lilian J. Meijboom, (unknown)	1
2	Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients 2024 ·Nature Communications ·(unknown), (unknown), James E. Peters, Harm Jan Bogaard, Jurjan Aman	8
3	Clinical Correlates of a Nonplexiform Vasculopathy in Patients With a Diagnosis of Idiopathic Pulmonary Arterial Hypertension 2024 ·CHEST Journal ·Esther J. Nossent, (unknown), (unknown), Lilian J. Meijboom, Anco Boonstra, Jurjan Aman, Frances S. de Man, Harm Jan Bogaard, Teodora Radonic, Peter Dorfmüller, Anton Vonk Noordegraaf	7
4	Deep phenotyping of pulmonary edema and pulmonary vascular permeability in COVID-19 ARDS 2024 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·(unknown), (unknown), (unknown), (unknown), Mihai G. Netea, Lilian J. Meijboom, Lieuwe D. J. Bos, Harm Jan Bogaard, Jurjan Aman	0
5	Integrated approach of network pharmacology, molecular docking, and clinical observations in evaluating the efficacy and safety of Bufei Huoxue capsules for pulmonary hypertension associated with chronic obstructive pulmonary disease 2024 ·Pulmonary Circulation ·Wenjun He, Chunli Liu, (unknown), (unknown), Qian Jiang, Ning Lai, (unknown), (unknown), Yilin Chen, (unknown), Defu Li, Wenju Lu, Jurjan Aman, Harm Jan Bogaard, Jian Wang, Yuqin Chen	0
6	Recurrent Pulmonary Veno-Occlusive Disease after Lung Transplantation 2024 ·American Journal of Respiratory and Critical Care Medicine ·Esther J. Nossent, G.D. Nossent, Lilian J. Meijboom, Erik A.M. Verschuuren, (unknown), Jurjan Aman, Harm Jan Bogaard, Teodora Radonic, Peter Dorfmüller, Anton Vonk Noordegraaf	0
7	Patients with CTEPH and mild hemodynamic severity of disease improve to a similar level of exercise capacity after pulmonary endarterectomy compared to patients with severe hemodynamic disease 2024 ·Pulmonary Circulation ·(unknown), (unknown), Paul Bresser, Lilian J. Meijboom, Petr Symersky, (unknown), Esther J. Nossent, Jurjan Aman, Harm Jan Bogaard, Anton Vonk Noordegraaf, Josien van Es	0
8	Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19 2023 ·Life Science Alliance ·Chiara E. Geyer, Hung‐Jen Chen, Alexander P. Bye, Xue D. Manz, Denise Guerra, Tom G. Caniels, Tom P. L. Bijl, Guillermo R. Griffith, Willianne Hoepel, Steven W. de Taeye, (unknown), Alexander P. J. Vlaar, (unknown), Gestur Vidarsson, Harm Jan Bogaard, Jurjan Aman, Jonathan M. Gibbins, Marit J. van Gils, Menno P.J. de Winther, Jeroen den Dunnen	6
9	The diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDS 2023 ·The Ultrasound Journal ·(unknown), (unknown), Mark E. Haaksma, Marry R. Smit, Harm Jan Bogaard, Leo Heunks, Nicole P. Juffermans, Marcus J. Schultz, Henrik Endeman, Patricia van Velzen, Pieter R. Tuinman, Jurjan Aman, Lieuwe D. J. Bos	3
10	Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients 2022 ·European Respiratory Journal ·Justin de Brabander, (unknown), (unknown), Patrick Smeele, Hessel Peters‐Sengers, JanWillem Duitman, Jurjan Aman, Harm Jan Bogaard, Tom van der Poll, Lieuwe D. J. Bos	19
11	A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension 2022 ·ERJ Open Research ·(unknown), (unknown), Marijke A.E. Mol, Kirsten A. Ziesemer, Martin R. Wilkins, Anton Vonk Noordegraaf, Harm Jan Bogaard, Jurjan Aman	13
12	Biomarkers of alveolar epithelial injury and endothelial dysfunction are associated with scores of pulmonary edema in invasively ventilated patients 2022 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·(unknown), Nanon F. L. Heijnen, Marry R. Smit, Laura A. Hagens, (unknown), (unknown), Marcus J. Schultz, Ronny M. Schnabel, Dennis C. J. J. Bergmans, Jurjan Aman, Lieuwe D. J. Bos	17
13	A modified perfusion protocol for pulmonary endarterectomy in a patient with a hematologic malignancy treated with a tyrosine kinase inhibitor 2021 ·Perfusion ·Renard Gerhardus Haumann, (unknown), (unknown), (unknown), (unknown), Jurjan Aman, Esther J. Nossent, Petr Symersky	0
14	Bosutinib prevents vascular leakage by reducing focal adhesion turnover and reinforcing junctional integrity 2020 ·Journal of Cell Science ·(unknown), (unknown), (unknown), John Liddle, (unknown), Jaap D. van Buul, Robert H. Bates, Pieter R. Tuinman, (unknown), Stephan Huveneers, Harm Jan Bogaard, Victor W.M. van Hinsbergh, Peter L. Hordijk, Jurjan Aman	26
15	In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time 2020 ·Journal of Visualized Experiments ·Xue D. Manz, Hugo J. Albers, Petr Symersky, Jurjan Aman, Andries D. van der Meer, Harm Jan Bogaard, Robert Szulcek	2
16	Dasatinib increases endothelial permeability leading to pleural effusion 2018 ·European Respiratory Journal ·Carole Phan, Étienne-Marie Jutant, Ly Tu, Raphaël Thuillet, Andrei Seferian, David Montani, Alice Huertas, Jan van Bezu, (unknown), Anton Vonk Noordegraaf, Marc Humbert, Jurjan Aman, Christophe Guignabert	62
17	Dasatinib increases endothelial permeability leading to pleural effusion 2018 ·Archives of Cardiovascular Diseases Supplements ·Carole Phan, Étienne-Marie Jutant, Ly Tu, Raphaël Thuillet, Andrei Seferian, David Montani, Alice Huertas, Jan van Bezu, (unknown), A. Vonk Noordegraaf, Marc Humbert, Jurjan Aman, Christophe Guignabert	16
18	Plasma Biomarkers for Acute Respiratory Distress Syndrome 2013 ·Critical Care Medicine ·(unknown), Jurjan Aman, Geerten P. van Nieuw Amerongen, A. B. Johan Groeneveld	133
19	Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome* 2010 ·Critical Care Medicine ·Jurjan Aman, M. van der Heijden, Arthur van Lingen, Armand R. J. Girbes, Geerten P. van Nieuw Amerongen, Victor W.M. van Hinsbergh, A. B. Johan Groeneveld	65
20	cAMP analogues downregulate the expression of granulocyte macrophage colony‐stimulating factor (GM‐CSF) in human bone marrow stromal cells in vitro 1998 ·Mediators of Inflammation ·Gesine Bug, Jurjan Aman, Christoph Huber, Christian Peschel, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact